Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Validation of Pain Assessment Scale Faces Thermometer Scale (FTS)

7 avril 2022 mis à jour par: Lund University

Validation of Pain Assessment Tool FTS

The aim of the study was to psychometrically evaluate the electronic self assessment Faces Pain Scale (FPS). Validation is performed in relation to golden standard of pain scale assessments Faces Pain Scale Reversed (FPS-R) and Coloured analogue Scale (CAS). 600 children with a range of illnesses on various paediatric healthcare settings in Sweden, Island, Denmark and USA will be included. Pain assessment will take place postoperatively, in relation to procedures or in a setting where acute pain is identified.

Aperçu de l'étude

Statut

Recrutement

Description détaillée

The Faces Pain Scale-Revised (FPS-R) and Coloured Analogue Scale (CAS), two commonly used analogue pain scales for self-report with good validity and reliability in psychometric evaluations with children 8-17 years of age were used as golden standard for study 1. A systematic review found strong recommendation for the use of FPS-R and CAS for acute pain and weak endorsement for post-operative pain in children above the age of seven9.

Procedure A convenience sample of total of 600 children 8-17 years of age will be enrolled in four groups with 150 children in each group based on a power calculation Group 1: Children with no pain. Group 2: Children experiencing acute pain requiring pain treatment/pain management. Group 3: Children who will undergo medical procedures that are associated with pain, e.g., intramuscular injections, lumbar punctures, and wound care awakening and without strong sedatives. Group 4: Children who will undergo minor surgery. The data collection follows a predetermined study protocol, estimated time for data collection is six to twelve months at each site to fulfil power calculation requisites. Prior to data collection, a pilot study will be done with children (n=20) at Skåne University Hospital and the study protocol will be evaluated for cultural sensitivity with children (n=5) in each country. All assessments will be performed in the child's primary language. In all encounters the words "hurt" or "pain" will be used interchangeably, depending on what seem to be most understandable for each child. The attending nurse/physician will identify eligible study participants and provides the child and the child's caregivers with oral and written information about the study and seeks formal informed consent. The child will be allocated a personal study code. The code also determines the randomized order of pain assessment, i.e., FTS→FPS-R→CAS; CAS→FTS→FPS-R; FPS-R→CAS→FTS which will be used for all assessments by the child to avoid assessment bias. The nurse will present each of the three scales to the child in the same order as assigned to the particular child for the assessment. Data on pain assessment will be collected at specific time points according to which of the four groups it is (Figure 4).

Data from the digital FTS assessment will be transformed by the nurse and documented together with data from FPS-R and CAS into a coded individual paper study form. At all follow- up assessments the child will be asked if he/she experiences more, less, or about the same level of pain as at the previous assessment.

Psychometric properties in terms of validity and reliability of the FTS in relation to the FPS-R and the CAS in our study population will be determined by the use of comparative statistics. Most adequate tests (e.g., Pearson's or Spearman's correlation, regression analysis) will be chosen s depending on data distribution. For group 1 a cut-off score at 0-3 and for group 2 cut-off at 4-10 will be used.

Convergent validity will be assessed by determining correlations and agreement between the FTS, the FPS-R and the CAS for self-assessing pain in children. Discriminative validity (being part of convergent validity) will be assessed to determine to what extent the FTS actually measure only the construct pain, and not something else (e.g., anxiety) by comparing the initial mean FTS, FPS-R, and CAS scores in children with painful conditions, versus those with non-painful conditions. Construct validity (responsivity) in children with painful conditions will be determined by comparing the initial mean FTS, FPS-R, and CAS pain scores with their respective post-treatment pain score. Children with no pain will be assessed in a similar fashion and expect that there should be no difference between the initial and 30-45-minute scores. Reliability (the degree to which pain scores are consistent from one assessment to the next) will be assessed by test-retest analysis in the subgroup of children with painful conditions reporting that their pain is "about the same" both pre- and post-treatment.

Demographic data, e.g., age, sex, native spoken language and ethnicity will be collected through a questionnaire filled out by the child or caregiver. Data on diagnosis, reason for care and information on pain management between assessment one and two, will be collected through a questionnaire in the study form filled out by the nurse. Study forms will be collected from the site by the research group (local PI at each site) and transformed and stored at a secure digital database at Lund University.

Pain assessment will be performed two - four times each with all three scales. Their ratings are documented digitally via the FTS Webb browser on the tablet that provides the scale and by the analogous on a study protocol by the nurse for the two analogue scales. The children provide background data on a questionnaire at baseline. Consecutive sampling will be performed to include another 100 children in 8-17 for evaluation of anticipated pain by the use of the Charleston Paediatric Pain Pictures (CPPP). The child is asked to grade the anticipated level of pain that they associate the illustration on each picture with. The researcher will encourage the child to describe how they reach their decision using a "think-aloud" method. The child's reasoning will be recorded and transcribed verbatim and analysed using a phenomenographic method.

Type d'étude

Interventionnel

Inscription (Anticipé)

600

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

      • Linköping, Suède
        • Recrutement
        • Universitetssjukhuset i Linköping
        • Contact:
          • Angelica Höök, RN
      • Lund, Suède, 22100
        • Recrutement
        • Skane University Hospital
        • Contact:
          • Pernilla Stenström, dr, ass prof

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

8 ans à 17 ans (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Children aged 8-17
  • Typically developed child
  • Child and caregiver with the ability to understand spoken Swedish

Exclusion Criteria:

• Children with unstable disease or in need of ICU

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Autre: Validation
Participants are introduced to all three painscales and are asked to rate their pain with each and one of them according to instructions for each scale

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Faces Thermometer Scale validity
Délai: Change in pain assessment at up to 4 hours
The Faces Thermometer Scale is a digital pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10. A higher reading indicates higher pain intensity.
Change in pain assessment at up to 4 hours

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Faces Thermometer Scale content validity validity
Délai: Change in pain assessment at up to 4 hours
The Faces Thermometer Scale is a digital pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10. A higher reading indicates higher pain intensity.
Change in pain assessment at up to 4 hours
Color Analog Scale validity
Délai: Change in pain assessment at 4 hours
The Color Analog Scale is an analog pain measure tool, which allows individuals to rate pain experience on a scale on a continuous scale which for the observer corresponds to a scale from 0 to 10 at intervals of 0.25. A higher reading indicates higher pain intensity.
Change in pain assessment at 4 hours
Faces Pain Scale-Revised validity
Délai: Up to 15 min
The Faces Pain Scale-Revised is an analog pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10 at intervals of 2. A higher reading indicates higher pain intensity.
Up to 15 min

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Les enquêteurs

  • Chercheur principal: charlotte castor, phd, Lund University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

17 septembre 2021

Achèvement primaire (Anticipé)

1 juin 2022

Achèvement de l'étude (Anticipé)

1 décembre 2022

Dates d'inscription aux études

Première soumission

10 novembre 2021

Première soumission répondant aux critères de contrôle qualité

7 avril 2022

Première publication (Réel)

15 avril 2022

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

15 avril 2022

Dernière mise à jour soumise répondant aux critères de contrôle qualité

7 avril 2022

Dernière vérification

1 avril 2022

Plus d'information

Termes liés à cette étude

Mots clés

Autres numéros d'identification d'étude

  • PR2020-0026

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner